Medicare’s Drug Program Enrollment Up, Costs Down

HealthDay News reported Thursday that the three-year-old Medicare Part D drug program is seeing the number of its enrollees climb, even as costs for the program fall.

The overall costs for Medicare Part D beneficiaries and taxpayers are lower than originally projected. The enrollments continue to rise and customer satisfaction remains very high. Many are still not excited, with many still faulting the program for its complexity, its high co-pays on some drugs and its inability to negotiate lower prices with the drug industry.According to article, the projected cost for Medicare part D is $117 billion lower over the next decade than experts estimated just last summer. At the same time, after the third open enrollment period that ended in December, the plan now has an additional 1.5 million people.Overall, there are about 25.4 million people enrolled in Part D. There are now 39.5 million people, most in Medicare, with some form of drug coverage.Drugcovergae is very important for individuals to think about. It could help lower monthly costs of precriptions dramatically.